Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
AFIBDelisted Stock | USD 0.73 0.03 3.95% |
About 62% of Acutus Medical's investor base is looking to short. The analysis of overall sentiment of trading Acutus Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Acutus Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Acutus Medical stock news signals to limit their universe of possible portfolio assets.
Acutus |
CARLSBAD, Calif., March 16, 2023 -- Acutus Medical, Inc. , an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2022. Financial statements and other information presented for 2022 is unaudited. Recent Highlights Reported revenue of 5.0 million for the fourth quarter of 2022, a 14 percent increase compared to
Read at finance.yahoo.com
Acutus Medical Fundamental Analysis
We analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Acutus Medical is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Acutus Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acutus Medical stock to make a market-neutral strategy. Peer analysis of Acutus Medical could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with similar companies.
Peers
Acutus Medical Related Equities
AIMD | Ainos | 4.44 | ||||
CVRX | CVRx | 3.20 | ||||
ATEC | Alphatec Holdings | 1.21 | ||||
AORT | Artivion | 0.95 | ||||
ANIK | Anika Therapeutics | 0.62 | ||||
LNSR | LENSAR | 0.46 | ||||
OFIX | Orthofix Medical | 0.06 | ||||
SSKN | STRATA Skin | 0.35 | ||||
DCTH | Delcath Systems | 0.87 | ||||
NPCE | Neuropace | 2.62 | ||||
AXDX | Accelerate Diagnostics | 2.73 | ||||
AXGN | Axogen | 5.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |